BTREX PLUS, Dietary Supplement 100 Caplets, UPC 05380930801

Lopez Gonzalez Santana Corporation recalled BTREX PLUS, Dietary Supplement 100 Caplets, UPC 05380930801 in a Class III action, the FDA tier used when a product is unlikely to cause adverse health effects, typically for labeling or minor regulatory issues on May 25, 2021.

The FDA-published reason for this recall is: "CGMP Deviations: Presence of damaged tablets"

Distribution was limited; the FDA record lists "Domestic distribution only-PR." Single-area recalls still warrant a kitchen check for anyone who shops within that footprint. The recalling firm is based in Rio Piedras, PR. The recall covers 894 bottles of product. The FDA has Terminated this recall (first reported Jun 23, 2021), its final lifecycle state, indicating the agency considers the corrective action resolved. The historical record remains useful for tracking a brand's recall pattern over time.